[HTML][HTML] Temporomandibular joint disorders: a review of etiology, clinical management, and tissue engineering strategies

MK Murphy, RF MacBarb, ME Wong… - … International journal of …, 2013 - ncbi.nlm.nih.gov
Epidemiology reports state temporomandibular joint disorders (TMD) affect up to 25% of the
population, yet their etiology and progression are poorly understood. As a result, treatment …

Hyaluronic acid injections for pain relief and functional improvement in patients with temporomandibular disorders: An umbrella review of systematic reviews

F Agostini, M Ferrillo, A Bernetti… - Journal of Oral …, 2023 - Wiley Online Library
Background Temporomandibular disorders (TMD) are the main cause of chronic facial pain,
and intra‐articular (IA) injections of hyaluronic acid (HA) are commonly performed …

[PDF][PDF] Pharmacotherapy in temporomandibular disorders: a review

A Ouanounou, M Goldberg, DA Haas - J Can Dent Assoc, 2017 - jcda.ca
Temporomandibular disorder (TMD) is a collective term that includes disorders of the
temporomandibular joint (TMJ) and of the masticatory muscles and their associated …

Temporomandibular joint regenerative medicine

X Van Bellinghen, Y Idoux-Gillet, M Pugliano… - International journal of …, 2018 - mdpi.com
The temporomandibular joint (TMJ) is an articulation formed between the temporal bone and
the mandibular condyle which is commonly affected. These affections are often so painful …

[HTML][HTML] Evaluation of the efficiency of hyaluronic acid, PRP and I-PRF intra-articular injections in the treatment of internal derangement of the temporomandibular joint …

S Vingender, F Dőri, P Schmidt, P Hermann… - Journal of Cranio …, 2023 - Elsevier
This study aimed to evaluate the clinical effects of hyaluronic acid (HA), platelet-rich plasma
(PRP), and platelet-rich fibrin (I-PRF) injections in the internal derangement of the …

Mesenchymal stem cells for cartilage regeneration of TMJ osteoarthritis

D Cui, H Li, X Xu, L Ye, X Zhou, L Zheng… - Stem Cells …, 2017 - Wiley Online Library
Temporomandibular joint osteoarthritis (TMJ OA) is a degenerative disease, characterized
by progressive cartilage degradation, subchondral bone remodeling, synovitis, and chronic …

Applications of hydrogels in drug delivery for oral and maxillofacial diseases

L Liu, D Wu, H Tu, M Cao, M Li, L Peng, J Yang - Gels, 2023 - mdpi.com
Oral and maxillofacial diseases have an important impact on local function, facial
appearance, and general health. As a multifunctional platform, hydrogels are widely used in …

Micro‐and nano‐carrier mediated intra‐articular drug delivery systems for the treatment of osteoarthritis

Z Zhang, G Huang - Journal of Nanotechnology, 2012 - Wiley Online Library
The objective of this paper is to provide readers with current developments of intra‐articular
drug delivery systems. In recent years, although the search for a clinically successful ideal …

Recent advancements in microspheres mediated targeted delivery for therapeutic interventions in osteoarthritis

A Rohila, R Shukla - Journal of Microencapsulation, 2024 - Taylor & Francis
Abstract Osteoarthritis (OA), affecting around 240 million people globally is a major threat.
Currently, available drugs only treat the symptoms of OA; they cannot reverse the disease's …

Optimally dosed nanoceria attenuates osteoarthritic degeneration of joint cartilage and subchondral bone

K Dashnyam, JH Lee, RK Singh, JY Yoon… - Chemical Engineering …, 2021 - Elsevier
Osteoarthritis entails excessive ROS generation, severe inflammatory responses, and
anatomical destruction of cartilage and subchondral bone. Nanoceria holds antioxidant …